WHAT WE DO
We focus on Wharton’s jelly mesenchymal stem cells research because of their stemness potential.
With minimal ethical concerns associated with the acquirement and use of these cells, WJ-MSCs offer ease of isolation, notable expansion and proliferative potential.
These cells possess low immunogenicity and high immunosuppressive capability, which make them useful
for therapeutic autologous and allogeneic applications.
Several preclinical and clinical studies have demonstrated the WJ-MSCs therapeutic potential in regenerative and reconstructive medicine, as well as the feasibility and safety of the treatments with no evidence of teratoma formation
or immune rejection.
We believe the future of medicine is centered on cell therapy.
Wharton’s Jelly Mesenchymal Stem Cells have emerged as a promising source
for regenerative medicine.
We want to improve people’s lives through WJ-MSCs research, and in the future,
we hope to develop new cell therapies to better people’s lives.
The Hematopoietic Transplant and Cellular Therapy Unit of the University of Murcia aims to carry out translational research to bridge the gap between basic and clinical biomedical research. This contributes to the treatment of human diseases through cell therapy and other advanced therapies.
TEAM UP WITH US
Could you get involved in our global research?
We invite organisations and institutions to get in touch and discuss the potential of research collaboration and partnerships.
Please complete the form below:
1927 Zonal Avenue, Los Angeles, CA 90033